-
1 Comment
Kusuri No Aoki Holdings Co., Ltd is currently in a long term downtrend where the price is trading 14.9% below its 200 day moving average.
From a valuation standpoint, the stock is 98.7% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 0.9.
Kusuri No Aoki Holdings Co., Ltd's total revenue rose by 1.2% to $76B since the same quarter in the previous year.
Its net income has increased by 7.2% to $4B since the same quarter in the previous year.
Based on the above factors, Kusuri No Aoki Holdings Co., Ltd gets an overall score of 3/5.
Industry | Pharmaceutical Retailers |
---|---|
Exchange | TSE |
CurrencyCode | JPY |
ISIN | JP3266190002 |
Sector | Healthcare |
Market Cap | 338B |
---|---|
Dividend Yield | 0.4% |
PE Ratio | 18.84 |
Target Price | 3880 |
Beta | 0.04 |
Kusuri No Aoki Holdings Co., Ltd. engages in the retail of pharmaceuticals, cosmetics, and daily goods in Japan. The company offers vitamin and diet supplements; and first aid and health care supplies. It also offers face wash, body soap, shampoo, and toothpaste, etc. In addition, the company provides baby products, such as diapers, nursing care, sanitary, detergents, and household products, as well as clothing products comprising of socks, underwear, and home appliances. Further, it offers processed foods, fresh foods, seasonings, and alcohol, etc. Additionally, the company provides pet foods. Kusuri No Aoki Holdings Co., Ltd. was incorporated in 1999 and is based in Hakusan, Japan.
Learn MoreHere's how to backtest a trading strategy or backtest a portfolio for 3549.TSE using our backtest tool. PyInvesting provides the backtesting software for you to backtest your investment strategy. Our backtest software is written using Python code and allows you to backtest stock, backtest etf, backtest options, backtest crypto and backtest forex online. Our backtesting Python framework is highly robust and gives you a realistic simulation of how your strategy would have performed in the past using backtest data.
© PyInvesting 2025